EUVIMEDEUVIMED entdecken
Crossref

Triglyceride Glucose Index and Urinary NGAL As Integrated Biomarkers For Diabetic Kidney Disease Progression: A Prospective Observational Study

Abhirami Etican Arumugam, Vaishnavi R, Sivaprakash S

International Journal of Drug Delivery Technology · 02.06.2026 · 16 (43s)

DOI: 10.25258/ijddt.16.43s.53 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.06.2026. Verfasst von Abhirami Etican Arumugam und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic kidney disease (DKD) remains a leading cause of end-stage renal disease worldwide, yet conventional markers such as urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) frequently fail to detect early renal injury. The triglyceride glucose (TyG) index, a surrogate marker of insulin resistance, and urinary neutrophil gelatinase-associated lipocalin (U-NGAL), a marker of tubular injury, may offer complementary diagnostic and prognostic value.

Methods

This prospective observational study enrolled 91 patients with type 2 diabetes mellitus and DKD (stages 2–4) alongside 50 healthy controls. Participants underwent clinical and laboratory assessment at baseline, 3 months, and 6 months. Measured parameters included fasting glucose, triglycerides, HbA1c, serum creatinine, eGFR, UACR, and U-NGAL. The TyG index was calculated from fasting triglyceride and glucose values. Statistical analyses included Pearson correlation, receiver operating characteristic (ROC) curves, and Cox proportional hazards modeling.

Results

Mean U-NGAL levels increased progressively from healthy controls (1.09 ± 0.22 ng/mL) to stage IV DKD (3.70 ± 0.18 ng/mL). U-NGAL demonstrated significant positive correlations with serum creatinine (r = 0.78, p < 0.001) and proteinuria (r = 0.65, p < 0.01), and negative correlation with eGFR (r = -0.72, p < 0.001). Baseline U-NGAL was significantly higher in disease progressors compared with non-progressors across all CKD stages (242.6 ± 85.3 vs. 173.4 ± 76.9 ng/mL, p < 0.001). Cox regression identified U-NGAL as an independent predictor of disease progression (HR 1.25, 95% CI 1.05–1.50, p = 0.01). ROC analysis demonstrated superior discriminative capacity for U-NGAL (AUC 0.80) compared with serum creatinine (AUC 0.68) in predicting progression.

Conclusion

U-NGAL demonstrates robust association with DKD severity and progression, providing complementary diagnostic information beyond conventional renal parameters. Integration of metabolic indices such as the TyG index with tubular injury markers may enhance early detection and risk stratification in diabetic kidney disease.

Zitieren

APA

Arumugam, A. E., R, V., & S, S. (2026). Triglyceride Glucose Index and Urinary NGAL As Integrated Biomarkers For Diabetic Kidney Disease Progression: A Prospective Observational Study. International Journal of Drug Delivery Technology, 16(43s). https://doi.org/10.25258/ijddt.16.43s.53

Vancouver

Arumugam AE, R V, S S. Triglyceride Glucose Index and Urinary NGAL As Integrated Biomarkers For Diabetic Kidney Disease Progression: A Prospective Observational Study. International Journal of Drug Delivery Technology. 2026;16(43s). doi:10.25258/ijddt.16.43s.53

BibTeX
@article{Arumugam2026,
  author = {Arumugam, Abhirami Etican and R, Vaishnavi and S, Sivaprakash},
  title = {Triglyceride Glucose Index and Urinary NGAL As Integrated Biomarkers For Diabetic Kidney Disease Progression: A Prospective Observational Study},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {43s},
  doi = {10.25258/ijddt.16.43s.53}
}
Kostenlos starten →